ETC-1002

CAS No. 738606-46-7

ETC-1002 ( ESP-55016;Bempedoic acid )

Catalog No. M15823 CAS No. 738606-46-7

A small molecule regulator of lipid and carbohydrate metabolism that targets ACC (acetyl-CoA carboxylase) with IC50 of 29 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 27 In Stock
5MG 43 In Stock
10MG 60 In Stock
25MG 114 In Stock
50MG 206 In Stock
100MG 332 In Stock
500MG 797 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ETC-1002
  • Note
    Research use only, not for human use.
  • Brief Description
    A small molecule regulator of lipid and carbohydrate metabolism that targets ACC (acetyl-CoA carboxylase) with IC50 of 29 uM.
  • Description
    A small molecule regulator of lipid and carbohydrate metabolism that targets ACC (acetyl-CoA carboxylase) with IC50 of 29 uM without activating the AMPK pathway in vitro; reduces circulating proatherogenic lipoproteins, hepatic lipids, and body weight in a hamster model of hyperlipidemia.Diabetes Phase 2 Clinical
  • Synonyms
    ESP-55016;Bempedoic acid
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    ACL
  • Research Area
    Metabolic Disease
  • Indication
    Diabetes

Chemical Information

  • CAS Number
    738606-46-7
  • Formula Weight
    344.49
  • Molecular Formula
    C19H36O5
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(O)C(C)(C)CCCCCC(O)CCCCCC(C)(C)C(O)=O
  • Chemical Name
    Pentadecanedioic acid, 8-hydroxy-2,2,14,14-tetramethyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Pinkosky SL, et al. J Lipid Res. 2013 Jan;54(1):134-51.
2. Cramer CT, et al. J Lipid Res. 2004 Jul;45(7):1289-301.
3. Filippov S, et al. J Lipid Res. 2013 Aug;54(8):2095-108.
molnova catalog
related products
  • Cimiracemoside C

    Cimiracemoside C is an active component of Cimicifuga racemosa. It activates AMPK and has the potential activity against diabetes.

  • PF-06885249

    PF-06885249 (PF06885249) is a potent, direct AMPK activator with EC50 of 7.0 and 27 nM for α1β1γ1 and α2β1γ1, respectively.

  • BC1618

    BC1618 is an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling.